AXIM BIOTECHNOLOGIES, INC. Revenue from Contract with Customer, Including Assessed Tax
AXIM BIOTECHNOLOGIES, INC. (AXIM) reported Revenue from Contract with Customer, Including Assessed Tax of $0 for the 3-month period ending 2022-06-30, per its 10-Q filed 2022-08-16.
Discontinued › Income Statement › Revenue
us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax · last filed 2022-08-16
- AXIM BIOTECHNOLOGIES, INC. revenue from contract with customer, including assessed tax for the quarter ending 2022-06-30 was $0.00, a 100.00% decline year-over-year.
- AXIM BIOTECHNOLOGIES, INC. revenue from contract with customer, including assessed tax for the quarter ending 2021-06-30 was $14.88K.
| Period end | Revenue from Contract with Customer, Including Assessed Tax 3 month | Revenue from Contract with Customer, Including Assessed Tax 6 month |
|---|---|---|
| 2022-06-30 | $0.00 10-Q · filed 2022-08-16 | $0.00 10-Q · filed 2022-08-16 |
| 2021-06-30 | $14.88K 10-Q · filed 2022-08-16 | $47.52K 10-Q · filed 2022-08-16 |